228 related articles for article (PubMed ID: 18593918)
1. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
Narasimhan M; Ammanamanchi S
Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
[TBL] [Abstract][Full Text] [Related]
2. Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2008 Feb; 283(9):5335-43. PubMed ID: 18165235
[TBL] [Abstract][Full Text] [Related]
3. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
[TBL] [Abstract][Full Text] [Related]
4. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
[TBL] [Abstract][Full Text] [Related]
5. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
Park JS; Park JH; Khoi PN; Joo YE; Jung YD
Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells.
Park JS; Park JH; Lee S; Joo YE; Jung YD
Oncol Rep; 2010 Sep; 24(3):709-14. PubMed ID: 20664977
[TBL] [Abstract][Full Text] [Related]
7. Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells.
Xia Y; Lian S; Khoi PN; Yoon HJ; Han JY; Chay KO; Kim KK; Jung YD
Int J Oncol; 2015 Apr; 46(4):1835-43. PubMed ID: 25625479
[TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutational status of RON in neoplastic lesions of the breast: analysis of MSP/RON signaling in ductal carcinoma in situ and invasive ductal carcinoma.
Ren X; Daa T; Yada N; Kashima K; Fujitomi Y; Yokoyama S
APMIS; 2012 May; 120(5):358-67. PubMed ID: 22515290
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
[TBL] [Abstract][Full Text] [Related]
11. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
Feres KJ; Ischenko I; Hayman MJ
Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
[TBL] [Abstract][Full Text] [Related]
12. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression.
Chen YQ; Fisher JH; Wang MH
J Immunol; 1998 Nov; 161(9):4950-9. PubMed ID: 9794431
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis.
Ukaji T; Lin Y; Okada S; Umezawa K
Biochem Biophys Res Commun; 2017 Mar; 485(1):76-81. PubMed ID: 28188787
[TBL] [Abstract][Full Text] [Related]
14. Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.
Thangasamy A; Rogge J; Krishnegowda NK; Freeman JW; Ammanamanchi S
J Biol Chem; 2011 Sep; 286(37):32115-22. PubMed ID: 21799005
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
[TBL] [Abstract][Full Text] [Related]
16. RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma.
Kim SA; Yoon TM; Lee DH; Park YL; Lee KH; Lim SC; Joo YE; Lee JK
Auris Nasus Larynx; 2014 Apr; 41(2):201-6. PubMed ID: 24287326
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response-1 in gastric cancer cells.
Lee KE; Park JS; Khoi PN; Joo YE; Lee YH; Jung YD
J Cell Biochem; 2012 Apr; 113(4):1217-23. PubMed ID: 22095683
[TBL] [Abstract][Full Text] [Related]
18. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
19. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
Iwama A; Yamaguchi N; Suda T
EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
[TBL] [Abstract][Full Text] [Related]
20. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
Wang MH; Yao HP; Zhou YQ
Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
